These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 11274621)

  • 61. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical experience with Oka live varicella vaccine in Japan.
    Takahashi M; Kamiya H; Baba K; Asano Y; Ozaki T; Horiuchi K
    Postgrad Med J; 1985; 61 Suppl 4():61-7. PubMed ID: 3014479
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.
    Vessey SJ; Chan CY; Kuter BJ; Kaplan KM; Waters M; Kutzler DP; Carfagno PA; Sadoff JC; Heyse JF; Matthews H; Li S; Chan IS
    J Pediatr; 2001 Aug; 139(2):297-304. PubMed ID: 11487760
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Live varicella vaccine in healthy individuals.
    Just M; Berger R; Luescher D
    Postgrad Med J; 1985; 61 Suppl 4():129-32. PubMed ID: 3014469
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Challenges in confirming a varicella outbreak in the two-dose vaccine era.
    Mahamud A; Wiseman R; Grytdal S; Basham C; Asghar J; Dang T; Leung J; Lopez A; Schmid DS; Bialek SR
    Vaccine; 2012 Nov; 30(48):6935-9. PubMed ID: 22884663
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Severe and Complicated Varicella and Associated Genotypes 10 Years After Introduction of a One-Dose Varicella Vaccine Program.
    Marshall HS; Clarke M; Heath C; Quinn H; Richmond PC; Crawford N; Elliott E; Toi C; Kynaston A; Booy R; Macartney K;
    J Infect Dis; 2019 Jan; 219(3):391-399. PubMed ID: 30184182
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Laboratory characteristics of suspected herpes zoster in vaccinated children.
    Chun C; Weinmann S; Riedlinger K; Mullooly JP; Houston H; Schmid DS; Seward JF
    Pediatr Infect Dis J; 2011 Aug; 30(8):719-21. PubMed ID: 21346684
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Contagiousness of varicella in vaccinated cases: a household contact study.
    Seward JF; Zhang JX; Maupin TJ; Mascola L; Jumaan AO
    JAMA; 2004 Aug; 292(6):704-8. PubMed ID: 15304467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A controlled trial of acyclovir for chickenpox in normal children.
    Dunkle LM; Arvin AM; Whitley RJ; Rotbart HA; Feder HM; Feldman S; Gershon AA; Levy ML; Hayden GF; McGuirt PV
    N Engl J Med; 1991 Nov; 325(22):1539-44. PubMed ID: 1944438
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, pennsylvania, 2006.
    Nguyen MD; Perella D; Watson B; Marin M; Renwick M; Spain CV
    Pediatr Infect Dis J; 2010 Aug; 29(8):685-9. PubMed ID: 20354463
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine.
    Vázquez M
    Curr Opin Pediatr; 2004 Feb; 16(1):80-4. PubMed ID: 14758119
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Varicella in infants after implementation of the US varicella vaccination program.
    Chaves SS; Lopez AS; Watson TL; Civen R; Watson B; Mascola L; Seward JF
    Pediatrics; 2011 Dec; 128(6):1071-7. PubMed ID: 22123875
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Varicella vaccination coverage in Bavaria (Germany) after general vaccine recommendation in 2004.
    Streng A; Seeger K; Grote V; Liese JG
    Vaccine; 2010 Aug; 28(35):5738-45. PubMed ID: 20600490
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Varicella vaccination in children with lymphoma and solid tumours.
    Emir S; Büyükpamukçu M; Köseoğlu V; Hasçelik G; Akyüz C; Kutluk T; Varan A
    Postgrad Med J; 2006 Nov; 82(973):760-2. PubMed ID: 17099098
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Don't forget how severe varicella can be--complications of varicella in children in a defined Polish population.
    Gowin E; Wysocki J; Michalak M
    Int J Infect Dis; 2013 Jul; 17(7):e485-9. PubMed ID: 23352485
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Analysis of protective effect of using chickenpox live attenuated vaccine among 4-17 years old children in Minhang district, Shanghai].
    Du Y; Yu F; Zhang L; Wang X; Jin B; Wang Y; Mei K; Lu J; Jiang L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1048-52. PubMed ID: 25619214
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluating the effectiveness of the universal immunization program against varicella in Japanese children.
    Hattori F; Miura H; Sugata K; Yoshikawa A; Ihira M; Yahata Y; Kamiya H; Tanaka-Taya K; Yoshikawa T;
    Vaccine; 2017 Sep; 35(37):4936-4941. PubMed ID: 28784281
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost-effectiveness analysis of varicella vaccine as post-exposure prophylaxis in Hong Kong.
    Chui KS; Wu HL; You JH
    Scand J Infect Dis; 2014 Jan; 46(1):27-33. PubMed ID: 24228821
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
    Macartney K; McIntyre P
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001833. PubMed ID: 18646079
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effectiveness of the Oka/GSK attenuated varicella vaccine for the prevention of chickenpox in clinical practice in Israel.
    Sheffer R; Segal D; Rahamani S; Dalal I; Linhart Y; Stein M; Shohat T; Somekh E
    Pediatr Infect Dis J; 2005 May; 24(5):434-7. PubMed ID: 15876943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.